Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- 2019-nCoV Vaccine mRNA-1273 1
- Abortion, Spontaneous 1
- ACIP meeting: 2021 Dec 16 1
- ACIP meeting: 2022 Apr 20 1
- Ad26COVS1 1
- Adolescent 24
- Adult 24
- Adverse Drug Reaction Reporting Systems 6
- Advisory Committees 14
- Aged 6
- Aged, 80 and over 2
- Age Factors 1
- Algorithms 2
- Aluminum 1
- anaphylaxis 2
- Anaphylaxis 1
- Antacids 1
- Antigens 1
- Antigens, Viral 1
- Appendicitis 1
- Article 10
- Asthma 2
- Bias 1
- Biometry 1
- Birth Weight 1
- Blood Group Antigens 1
- BNT162 Vaccine 2
- Breast Feeding 1
- Bursitis 1
- California 1
- Cardiovascular Diseases 1
- Case-Control Studies 3
- Cause of Death 1
- Centers for Disease Control and Prevention, U.S. 2
- Child 20
- Child, Preschool 11
- Cohort Studies 6
- CoronaVirus Infections 7
- Coronavirus Infections 2
- Coronavirus Infections/prevention &control 13
- Coronavirus Infections/prevention & control 6
- COVID-19 20
- COVID-19 Vaccines 42
- COVID-19 Vaccines/adverse effects 1
- COVID-19/prevention & control 8
- COVID-19/Prevention & Control 1
- COVID-19/prevention &control 1
- Diphtheria-Tetanus-acellular Pertussis Vaccines 3
- Drug-Related Side Effects and Adverse Reactions 3
- Drug Approval 7
- Electronic Health Records 6
- Female 27
- Hospitalization 2
- Humans 43
- Immunization 9
- Immunization, Secondary 12
- Immunization/standards 2
- Immunization Schedule 8
- Incidence 5
- Infant 11
- Infant, Newborn 5
- Influenza, Human 5
- Influenza Vaccines 8
- Male 20
- Middle Aged 14
- Natural Language Processing 2
- Pandemics 6
- Papillomavirus Infections 3
- Papillomavirus Vaccines 3
- Patient Safety 4
- pharmacoepidemiology 2
- Population Surveillance 2
- Practice Guidelines as Topic 6
- Pregnancy 9
- Pregnancy Complications, Infectious 2
- Pregnancy Outcome 2
- Pregnant Women 2
- Premature Birth 2
- Prevalence 3
- Proportional Hazards Models 2
- Retrospective Studies 12
- Risk Assessment 5
- Risk Factors 4
- RNA, Messenger 2
- Safety 2
- SARS-CoV-2 5
- Seasons 3
- Severity of Illness Index 2
- Surveys and Questionnaires 3
- United States 7
- Vaccination 44
- Vaccination Coverage 4
- Vaccines 5
- Vaccines, Attenuated 3
- Vaccines, Synthetic 3
- vaccine safety 3
- Viral Vaccine 2
- Viral Vaccines 5
- Whooping Cough 2
- Young Adult 16
Personal Author
Corporate Author
- Arkansas. Department of Arkansas. Department of Health. 1
- Arkansas. Department of Health. 2
- Carter Consulting, Inc. 1
- CDC COVID-19 Response Team. 7
- Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region) 1
- Centers for Disease Control and Prevention (U.S.) 1
- Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service. 4
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. 1
- Denver Health. 1
- Franny Strong Foundation (West Bloomfield, Michigan) 2
- Harvard Medical School. 1
- Harvard Medical School. Massachusetts General Hospital. 1
- Harvard Pilgrim Health Care Institute. 1
- HealthPartners Institute, Minneapolis, Minnesota 1
- HealthPartners Institute. 2
- Kaiser-Permanente Medical Care Program. Southern California Region. Research and Evaluation. 1
- Kaiser Colorado, Denver. 1
- Kaiser Permanente. Institute for Health Research. 1
- Kaiser Permanente Colorado. Institute for Health Research. 8
- Kaiser Permanente Institute for Health Research. 1
- Kaiser Permanente Northern California. Division of Research. 1
- Kaiser Permanente Northern California. Vaccine Study Center. 1
- Kaiser Permanente Northwest. Center for Health Research, 1
- Kaiser Permanente Washington Health Research Institute. 1
- Kaiser Southern California. 1
- Leidos, Inc. 1
- Marshfield Clinic, Marshfield. 1
- Marshfield Clinic. Research Laboratory. 1
- Marshfield Clinic Research Institute. 1
- McMaster University. Faculty of Health Sciences. Department of Health Research Methods, Evidence, and Impact. 4
- National Center for Emerging and Zoonotic Infections (U.S.) 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Global Migration and Quarantine. 1
- National Center for Emerging Zoonotic and Infectious Diseases (U.S.)Division of Healthcare Quality Promotion. 1
- National Center for Immunization and Respiratory Diseases (U.S.)Immunization Services Division. 1
- New York University Grossman School of Medicine. 1
- Ohio State University College of Medicine. Nationwide Children’s Hospital. 1
- Stanford University School of Medicine. 6
- Total Solutions, Inc. 1
- U.S. Advisory Committee on Immunization Practices 1
- United States. Advisory Committee on Immunization Practices. 8
- United States. Advisory Committee on Immunization Practices. ACIP COVID-19 Vaccines Work Group. 1
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. 22
- United States. Food and Drug Administration. 1
- United States Advisory Committee on Immunization Practices. 1
- University of Arizona. College of Medicine. 3
- University of Arizona College of Medicine. 1
- University of Washington. 3
- Vaccine Safety Datalink 1
- Vanderbilt University School of Medicine. 6
- Watts Healthcare Corporation. 3
- Yale University. 1
Place as Subject
- Alabama 1
- Arizona 1
- Colorado 1
- Indiana 1
- Los Angeles, CA 1
- Louisiana 1
- Maryland 1
- Minnesota 1
- New Mexico 1
- New York City, NY 1
- North Carolina 1
- Seattle, WA 1
- U.S. 3
- United States 19
- Utah 1
Resource Type General
- Journal Article 54
- Presentation 24
Resource Type Specific
Keywords
- Accuracy 1
- Adolescents 1
- Adults 1
- Aluminum 1
- aluminum 1
- asthma 2
- Asthma 1
- Attitudes 1
- case-control 1
- Child 2
- child 1
- Child, Preschool 1
- Chlorination 1
- Clinical notes 1
- Co-administration 1
- combined 1
- Coverage 1
- COVID-19 vaccines 3
- Disparities 1
- Eczema 1
- Electronic health record 1
- Electronic health records 2
- Emergency Use Authorization 1
- Hepatitis B vaccine 1
- herpes zoster 1
- Household water treatment 1
- Human papillomavirus vaccine 1
- Humans 2
- Immunization 2
- immunization 2
- Influenza 1
- Influenza vaccination 2
- managed-care programs 1
- Mortality 1
- mRNA covid-19 bivalent booster vaccine 1
- Natural language processing 1
- Patient Acceptance of Health Care 1
- population surveillance 1
- Pregnancy 2
- pregnancy 1
- Retrospective Studies 2
- Safety 1
- safety 1
- Safe water storage 1
- SARS-CoV-2 1
- Schedule 1
- Seasonal influenza vaccine 1
- Self-report 1
- sequential analysis 1
- shingles 1
- Simultaneous vaccination 1
- spontaneous abortion 1
- study design 1
- surveillance 1
- Travel 1
- Travel-Related Illness 1
- traveler 1
- travel information 1
- travel vaccine 1
- Typhoid-Paratyphoid Vaccines 1
- Under-vaccination 1
- undervaccination 1
- United States 1
- Vaccination 2
- Vaccination coverage 1
- Vaccine 1
- vaccine 1
- vaccine-associated enhanced disease 1
- Vaccine adverse event 1
- Vaccines 1
- vaccines 1
- Vaccine safety 5
- vaccine safety 5
- vaccine schedule 2
- Vaccine schedule 1
- Vaccine uptake 1
- Venous thromboembolism 1
- zoster vaccine 1
Select all docs (Max 200)
41 -
60 of 78 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 2019-nCoV Vaccine mRNA-1273 (1)
- Abortion, Spontaneous (1)
- ACIP meeting: 2021 Dec 16 (1)
- ACIP meeting: 2022 Apr 20 (1)
- Ad26COVS1 (1)
- Adolescent (24)
- Adult (24)
- Adverse Drug Reaction Reporting Systems (6)
- Advisory Committees (14)
- Aged (6)
- Aged, 80 and over (2)
- Age Factors (1)
- Algorithms (2)
- Aluminum (1)
- anaphylaxis (2)
- Anaphylaxis (1)
- Antacids (1)
- Antigens (1)
- Antigens, Viral (1)
- Appendicitis (1)
- Article (10)
- Asthma (2)
- Bias (1)
- Biometry (1)
- Birth Weight (1)
- Blood Group Antigens (1)
- BNT162 Vaccine (2)
- Breast Feeding (1)
- Bursitis (1)
- California (1)
- Cardiovascular Diseases (1)
- Case-Control Studies (3)
- Cause of Death (1)
- Centers for Disease Control and Prevention, U.S. (2)
- Child (20)
- Child, Preschool (11)
- Cohort Studies (6)
- CoronaVirus Infections (7)
- Coronavirus Infections (2)
- Coronavirus Infections/prevention &control (13)
- Coronavirus Infections/prevention & control (6)
- COVID-19 (20)
- COVID-19 Vaccines (42)
- COVID-19 Vaccines/adverse effects (1)
- COVID-19/prevention & control (8)
- COVID-19/Prevention & Control (1)
- COVID-19/prevention &control (1)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (3)
- Drug-Related Side Effects and Adverse Reactions (3)
- Drug Approval (7)
- Electronic Health Records (6)
- Female (27)
- Hospitalization (2)
- Humans (43)
- Immunization (9)
- Immunization, Secondary (12)
- Immunization/standards (2)
- Immunization Schedule (8)
- Incidence (5)
- Infant (11)
- Infant, Newborn (5)
- Influenza, Human (5)
- Influenza Vaccines (8)
- Male (20)
- Middle Aged (14)
- Natural Language Processing (2)
- Pandemics (6)
- Papillomavirus Infections (3)
- Papillomavirus Vaccines (3)
- Patient Safety (4)
- pharmacoepidemiology (2)
- Population Surveillance (2)
- Practice Guidelines as Topic (6)
- Pregnancy (9)
- Pregnancy Complications, Infectious (2)
- Pregnancy Outcome (2)
- Pregnant Women (2)
- Premature Birth (2)
- Prevalence (3)
- Proportional Hazards Models (2)
- Retrospective Studies (12)
- Risk Assessment (5)
- Risk Factors (4)
- RNA, Messenger (2)
- Safety (2)
- SARS-CoV-2 (5)
- Seasons (3)
- Severity of Illness Index (2)
- Surveys and Questionnaires (3)
- United States (7)
- Vaccination (44)
- Vaccination Coverage (4)
- Vaccines (5)
- Vaccines, Attenuated (3)
- Vaccines, Synthetic (3)
- vaccine safety (3)
- Viral Vaccine (2)
- Viral Vaccines (5)
- Whooping Cough (2)
- Young Adult (16)
- Arkansas. Department of Arkansas. Department of Health. (1)
- Arkansas. Department of Health. (2)
- Carter Consulting, Inc. (1)
- CDC COVID-19 Response Team. (7)
- Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region) (1)
- Centers for Disease Control and Prevention (U.S.) (1)
- Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service. (4)
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. (1)
- Denver Health. (1)
- Franny Strong Foundation (West Bloomfield, Michigan) (2)
- Harvard Medical School. (1)
- Harvard Medical School. Massachusetts General Hospital. (1)
- Harvard Pilgrim Health Care Institute. (1)
- HealthPartners Institute, Minneapolis, Minnesota (1)
- HealthPartners Institute. (2)
- Kaiser-Permanente Medical Care Program. Southern California Region. Research and Evaluation. (1)
- Kaiser Colorado, Denver. (1)
- Kaiser Permanente. Institute for Health Research. (1)
- Kaiser Permanente Colorado. Institute for Health Research. (8)
- Kaiser Permanente Institute for Health Research. (1)
- Kaiser Permanente Northern California. Division of Research. (1)
- Kaiser Permanente Northern California. Vaccine Study Center. (1)
- Kaiser Permanente Northwest. Center for Health Research, (1)
- Kaiser Permanente Washington Health Research Institute. (1)
- Kaiser Southern California. (1)
- Leidos, Inc. (1)
- Marshfield Clinic, Marshfield. (1)
- Marshfield Clinic. Research Laboratory. (1)
- Marshfield Clinic Research Institute. (1)
- McMaster University. Faculty of Health Sciences. Department of Health Research Methods, Evidence, and Impact. (4)
- National Center for Emerging and Zoonotic Infections (U.S.) (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Global Migration and Quarantine. (1)
- National Center for Emerging Zoonotic and Infectious Diseases (U.S.)Division of Healthcare Quality Promotion. (1)
- National Center for Immunization and Respiratory Diseases (U.S.)Immunization Services Division. (1)
- New York University Grossman School of Medicine. (1)
- Ohio State University College of Medicine. Nationwide Children’s Hospital. (1)
- Stanford University School of Medicine. (6)
- Total Solutions, Inc. (1)
- U.S. Advisory Committee on Immunization Practices (1)
- United States. Advisory Committee on Immunization Practices. (8)
- United States. Advisory Committee on Immunization Practices. ACIP COVID-19 Vaccines Work Group. (1)
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. (22)
- United States. Food and Drug Administration. (1)
- United States Advisory Committee on Immunization Practices. (1)
- University of Arizona. College of Medicine. (3)
- University of Arizona College of Medicine. (1)
- University of Washington. (3)
- Vaccine Safety Datalink (1)
- Vanderbilt University School of Medicine. (6)
- Watts Healthcare Corporation. (3)
- Yale University. (1)
- Accuracy (1)
- Adolescents (1)
- Adults (1)
- Aluminum (1)
- aluminum (1)
- asthma (2)
- Asthma (1)
- Attitudes (1)
- case-control (1)
- Child (2)
- child (1)
- Child, Preschool (1)
- Chlorination (1)
- Clinical notes (1)
- Co-administration (1)
- combined (1)
- Coverage (1)
- COVID-19 vaccines (3)
- Disparities (1)
- Eczema (1)
- Electronic health record (1)
- Electronic health records (2)
- Emergency Use Authorization (1)
- Hepatitis B vaccine (1)
- herpes zoster (1)
- Household water treatment (1)
- Human papillomavirus vaccine (1)
- Humans (2)
- Immunization (2)
- immunization (2)
- Influenza (1)
- Influenza vaccination (2)
- managed-care programs (1)
- Mortality (1)
- mRNA covid-19 bivalent booster vaccine (1)
- Natural language processing (1)
- Patient Acceptance of Health Care (1)
- population surveillance (1)
- Pregnancy (2)
- pregnancy (1)
- Retrospective Studies (2)
- Safety (1)
- safety (1)
- Safe water storage (1)
- SARS-CoV-2 (1)
- Schedule (1)
- Seasonal influenza vaccine (1)
- Self-report (1)
- sequential analysis (1)
- shingles (1)
- Simultaneous vaccination (1)
- spontaneous abortion (1)
- study design (1)
- surveillance (1)
- Travel (1)
- Travel-Related Illness (1)
- traveler (1)
- travel information (1)
- travel vaccine (1)
- Typhoid-Paratyphoid Vaccines (1)
- Under-vaccination (1)
- undervaccination (1)
- United States (1)
- Vaccination (2)
- Vaccination coverage (1)
- Vaccine (1)
- vaccine (1)
- vaccine-associated enhanced disease (1)
- Vaccine adverse event (1)
- Vaccines (1)
- vaccines (1)
- Vaccine safety (5)
- vaccine safety (5)
- vaccine schedule (2)
- Vaccine schedule (1)
- Vaccine uptake (1)
- Venous thromboembolism (1)
- zoster vaccine (1)
- :Daley, Matthew F.February 28, 2024 | ACIP meeting COVID-19 Vaccines:01-COVID-Daley-508.pdf
- :Hesse, Elisabeth M. ;Navarro, Ronald A.8 18 2020 | Ann Intern Med. 173(4):253-261:Background:Subdeltoid bursitis has been reported as an adverse event after intramuscular vaccination in the deltoid muscle. Most published case report...
- :Kempe, Allison ;O’Leary, Sean T.Feb 26 2016 | Pediatrics. 137(3):e20152857.:OBJECTIVESCompletion rates for the human papillomavirus vaccine (HPV) series among adolescents remain low. Effectiveness of recall with parents choosi...
- :Daley, Matthew F.June 27, 2024 | ACIP meeting COVID-19 Vaccines:01-COVID-Daley-508.pdf
- :Nelson, Jennifer C. ;Ulloa-Pérez, Ernesto10 04 2022 | Am J Epidemiol. 192(2):205-216:Recombinant zoster vaccine (RZV) (Shingrix; GlaxoSmithKline, Brentford, United Kingdom) is an adjuvanted glycoprotein vaccine that was licensed in 201...
- :Denoble, Anna E. ;Vazquez-Benitez, Gabriela8 2024 | Obstet Gynecol. 144(2):215-222:OBJECTIVE:Coronavirus disease 2019 (COVID-19) vaccination is recommended in pregnancy to reduce the risk of severe morbidity from COVID-19. However, v...
- :Irving, Stephanie A. ;Groom, Holly C.11 22 2023 | Vaccine. 41(48):7138-7146:Background:In the United States, annual vaccination against seasonal influenza is recommended for all people ages ≥ 6 months. Vaccination coverage a...
- :Daley, Matthew F. ;Shoup, Jo Ann2018 | Acad Pediatr. 18(7):754-762:Objectives:Some parents are concerned the childhood immunization schedule could increase risk for allergic disorders, including asthma. To inform futu...
- :Daley, Matthew F. ;Glanz, Jason M.4 04 2017 | Vaccine. 35(15):1873-1878:Background:To address public concern about the safety of the childhood immunization schedule, the Institute of Medicine recommended observational stud...
- Influenza vaccination accuracy among adults: Self-report compared with electronic health record data:Daley, Matthew F. ;Reifler, Liza M.4-19- | Vaccine. 42(11):2740-2746:Objective:To assess the validity of electronic health record (EHR)-based influenza vaccination data among adults in a multistate network.Methods:Follo...
- :Markowitz, Lauri E. ;Hopkins, Robert H.9 17 2024 | Vaccine. 42(Suppl 3):125549:During the COVID-19 pandemic, candidate COVID-19 vaccines were being developed for potential use in the United States on an unprecedented, accelerated...
- :Groom, Holly C. ;Irving, Stephanie A.10 01 2018 | Vaccine. 36(41):6111-6116:Introduction:Hepatitis B virus (HBV) infection acquired during pregnancy can pose a risk to the infant at birth that can lead to significant and lifel...
- :Daley, Matthew F. ;Reifler, Liza M.12 2023 | Prev Med. 177:107751:Objective:Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States have been documented. This study a...
- :Vazquez-Benitez, Gabriela ;Haapala, Jacob L.8 04 2023 | Am J Epidemiol. 192(8):1386-1395:In the Vaccine Safety Datalink (VSD), we previously reported no association between coronavirus disease 2019 (COVID-19) vaccination in early pregnancy...
- :Kenigsberg, Tat’Yana A. ;Goddard, Kristin9 07 2023 | Vaccine. 41(39):5678-5682:The U.S. Food and Drug Administration authorized use of mRNA COVID-19 bivalent booster vaccines on August 31, 2022. Currently, CDC's clinical guidance...
- :McCarthy, Natalie L. ;Sukumaran, Lakshmi12 04 2017 | Vaccine. 35(48 Pt B):6643-6648:BackgroundEvidence supports the safety of the recommended childhood immunization schedule as a whole. However, additional research is warranted as par...
- :Zheng, Chengyi ;Yu, Wei7 2019 | Int J Med Inform. 127:27-34:Objective:Local reactions are the most common vaccine-related adverse event. There is no specific diagnosis code for local reaction due to vaccination...
- :Woodworth, Kate R. ;Moulia, Danielle11 12 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine is a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine encoding the prefusion spike glyc...
- :Lipkind, Heather S. ;Vazquez-Benitez, Gabriela1 07 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):COVID-19 vaccines are recommended during pregnancy to prevent severe maternal morbidity and adverse birth outcomes; however, vaccination coverage amon...